Skip to main content
. 2019 Aug 19;8(8):1251. doi: 10.3390/jcm8081251
rPFS radiographic progression-free survival
OS overall survival
CRPC castration-resistant prostate cancer
ASIs androgen signaling inhibitors
TTPP time to PSA progression
ADT androgen deprivation therapy
RCT randomized control trial
SCC Spearman’s correlation coefficient